Vinay Prasad, oncologist and Twitter star, locked in debate over precision medicine

By Paul Goldberg

In recent years, Vinay Prasad, a young hematologist–oncologist at Oregon Health and Science University, has emerged as a premier critic of new directions in cancer medicine.

Free

Reviews of Prasad's
“thought experiment”

By Paul Goldberg

Conversation with The Cancer Letter Free

Prasad: FDA has confused merely approving drugs with making the world a better place

By Paul Goldberg

Vinay Prasad, oncologist and Twitter star, locked in debate over precision medicine

Reviews of Prasad's
“thought experiment”

Prasad: FDA has confused merely approving drugs with making the world a better place

In Brief

Norman Coleman, Gay Crawford to receive NCCS Stovall Award for advancing patient-centered care

Marc Lippman, breast cancer expert, returns to Georgetown Lombardi

Laura Hutchins named interim director of UAMS Rockefeller Cancer Institute

Funding Opportunities

DOD Prostate Cancer Research Program opportunities

Clinical Roundup

Kymriah shows more than one-year durable responses in relapsed or refractory DLBCL

Lonsurf improves OS in metastatic gastric cancer

Greater levels of vitamin D associated with decreasing risk of breast cancer

Diabetes diagnosis later in life may signal early pancreatic cancer in African-Americans and Latinos

Study finds emergency colon cancer surgery performed on weekends more likely to lead to complications

Drugs & Targets

FDA to review BRACAnalysis CDx sPMA as companion diagnostic for Talazoparib

China's drug agency approves Opdivo for previously treated NSCLC

Natera, Institut Jules Bordet to collaborate on neoadjuvant breast cancer assay

Recent Issues

Renew today!

Subscriber content